It is unsafe to consume alcohol with Envelaf 150mg Capsule XR.
Envelaf 150mg Capsule XR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Envelaf 150mg Capsule XR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.<BR>Babies should be monitored for excessive sleepiness and adequate weight gain.
Envelaf 150mg Capsule XR may cause side effects which could affect your ability to drive.<BR>As side effects of Envelaf 150mg Capsule XR are dizziness, confusion and eye sight changes such as blurred vision and this may affect your ability to drive.
Envelaf 150mg Capsule XR should be used with caution in patients with kidney disease. Dose adjustment of Envelaf 150mg Capsule XR may be needed. Please consult your doctor.
Envelaf 150mg Capsule XR should be used with caution in patients with liver disease. Dose adjustment of Envelaf 150mg Capsule XR may be needed. Please consult your doctor.
Envelaf 150mg Capsule XR works by increasing the levels of chemical messengers (serotonin and noradrenaline), natural substances in the brain that help maintain mental balance.
No. Envelaf is not a narcotic drug. Narcotics are drugs with sleep inducing properties, usual derivatives of Opium like Heroin and Morphine.
No. Envelaf does not have habit-forming potential.
Yes. Envelaf can cause sedation. You should inform your doctor if you are taking any other sleep inducing medicines before starting Envelaf.
Envelaf is absorbed from the intestine after being metabolised by the liver.
Yes. Envelaf is known to cause constipation in some patients. Take a fiber-rich diet and drink plenty of water. You may consider taking laxatives as well. Your doctor will suggest ways to prevent or manage it. Please consult your doctor if it does not resolve or gets worse.
Envelaf treatment is associated with sustained increases in blood pressure in some people. It is recommended that people who are being treated with Envelaf should have regular monitoring of blood pressure. For such people, either dose reduction or discontinuation should be considered.
No. Citalopram and Envelaf both increase serotonin levels. Avoid or use any alternate drug. It can cause a serious condition called as serotonin syndrome. It is a potentially life-threatening can present as agitation, hallucinations, nausea, vomiting, diarrhoea, tachycardia, labile blood pressure, hyperthermia and coma.
Envelaf is a medication to treat generalised depressive disorder or depression. Consult your doctor before taking this medication.
No. There can be a serious side effect when mirtazapine is taken with Envelaf. It can cause a serious condition called as serotonin syndrome. It is a potentially life-threatening can present as agitation, hallucinations, nausea, vomiting, diarrhoea, tachycardia, labile blood pressure, hyperthermia and coma.
Envelaf is not approved for the treatment of fibromyalgia. Some research studies have shown promising results of Envelaf in the treatment of fibromyalgia. Consult your doctor before starting this medication.
Desvenlafaxine is an active metabolite of Envelaf. It is the same medication in an active form.
If you find any side effects like decreased sex drive or impotence talk to your doctor and then you can have some other drug. Do not stop Envelaf by yourself it can lead to increased adverse effects.
You can take a tablet instead of the capsule but only under consultation or prescription of a doctor. You should not change it yourself as the different formulation of a medication may have a different action as drug release would be different in both. This can lead to an inappropriate treatment and may lead to side effects or even failure of treatment.
Envelaf is known to cause changes in the neurotransmitters levels and chemicals in the brain which leads to decrease in appetite and this loss of appetite is dose dependent.
Envelaf is not approved for treatment of nerve pain disorders but some researchers have proved its efficacy in nerve pain. It is currently used off-label for nerve pain.
Yes. Envelaf is a psychotropic drug. Any medication capable of affecting the mind, emotions, and behaviour are called psychotropic drugs.
Yes. Gabapentin can be given with Envelaf but only with a consultation of a doctor. They both, when given together, causes an increase drowsiness, sleepiness and decreased concentration in work. Take with caution.
P-glycoprotein is responsible for the expulsion of Envelaf from the brain. Some studies have shown that Envelaf and its metabolite inhibit the p-glycoprotein.
Both are same medication. Envelaf ER and XR both means extended release preparation which releases the medication slowly into the body and maintains a constant needed medications levels. The advantage of taking ER/XR tablets is the frequency of dosage can be decreased.
Yes. Envelaf is known to cause weight loss in some patients. In research studies, a dose-dependent weight loss was noted in patients treated with Envelaf for several weeks. Please consult your doctor if it bothers you.
Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA